Aleris Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$2.5M
- Investors
-
2
Aleris Therapeutics General Information
Description
Operator of exploring novel anti-inflammatory mechanisms intended to treat immune-mediated conditions while avoiding the side effects of current standard therapies. The company is currently operating in Stealth Mode.
Contact Information
Corporate Office
- Victoria
- Australia
Corporate Office
- Victoria
- Australia
Aleris Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 13-Aug-2026 | $2.5M | Completed | Stealth | ||
| 1. Early Stage VC | Completed | Stealth |
Aleris Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Brandon Biocatalyst | Venture Capital | Minority | ||
| AbbVie Ventures | Corporate Venture Capital | Minority |
Aleris Therapeutics FAQs
-
Where is Aleris Therapeutics headquartered?
Aleris Therapeutics is headquartered in Australia.
-
What industry is Aleris Therapeutics in?
Aleris Therapeutics’s primary industry is Other Healthcare Technology Systems.
-
Is Aleris Therapeutics a private or public company?
Aleris Therapeutics is a Private company.
-
What is Aleris Therapeutics’s current revenue?
The current revenue for Aleris Therapeutics is .
-
How much funding has Aleris Therapeutics raised over time?
Aleris Therapeutics has raised $2.5M.
-
Who are Aleris Therapeutics’s investors?
Brandon Biocatalyst and AbbVie Ventures have invested in Aleris Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
